Alicja Kreczko, MD
Obstetrics & Gynecology · Providence, RINPI 1124314695
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations.
Across 110 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$439
- Exeltis, USA Inc.$247
- Astellas Pharma US Inc$237
- Pfizer$192
- Myovant Sciences Inc.$153
- Therapeuticsmd, Inc.$124
- plus $709 from 18 others
What the payments were for
- Food & beverage$2,102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $439 |
| Exeltis, USA Inc. | 14 | $247 |
| Astellas Pharma US Inc | 9 | $237 |
| Pfizer | 11 | $192 |
| Myovant Sciences Inc. | 8 | $153 |
| Therapeuticsmd, Inc. | 8 | $124 |
| Coopersurgical, Inc. | 4 | $88 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Mayne Pharma Commercial LLC | 3 | $61 |
| Bayer | 4 | $59 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Sage Therapeutics, LLC | 2 | $55 |
| Currax Pharmaceuticals LLC | 3 | $46 |
| Hologic Sales And Service, LLC | 1 | $37 |
| Mylan Pharmaceuticals Inc. | 2 | $37 |
| Merck | 2 | $29 |
| Avion Pharmaceuticals | 2 | $25 |
| Eisai Inc. | 1 | $24 |
| Agile Therapeutics, Inc. | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Organon | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Scynexis, Inc. | 1 | $17 |
| Lupin Inc. | 1 | $15 |
How this compares
$2,102 in reported general payments places this provider in the 75th percentile of 139 obstetrics & gynecology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| YuvafemEstradiol | 29 | $2,815 |
| Estradiol | 47 | $2,690 |
| Estradiol (Twice Weekly)Estradiol | 14 | $2,080 |
| ValacyclovirValacyclovir Hcl | 14 | $721 |
| ProgesteroneProgesterone, Micronized | 14 | $420 |
| Clobetasol Propionate | 11 | $318 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $185 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Providence
- Warren HuberProvidence$50K
- Lisa BoyleProvidence$30K
- Renee EgerProvidence$24K
- Gary WhartonProvidence$22K
- Christine FoleyProvidence$21K
- Cara MathewsProvidence$21K
- Michael BeitleProvidence$9K
- Ogechukwu EzikeProvidence$7K
- Beata DizoglioProvidence$6K
- Michele GangeProvidence$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.